The project “CVDLINK: A federated paradigm of real-world data sources utilization for the empowerment of diagnosis, prognosis and risk assessment of cardiovascular conditions” brings together 19 partners from 10 European countries and Israel. The project is coordinated by SIMAVI, a Romanian advanced software company; other project partners include universities, research institutes and companies from Lithuania, Germany, Ireland, Greece, Austria, Finland, Spain, Moldova and Estonia. The 4-year project is funded by the EU research and innovation programme “Horizon Europe”.
More than 6 million new cases of cardiovascular disease (CVD) are reported each year in the European Union, causing 1.8 million deaths. This is a significant burden on healthcare systems and society. Effective interventions are expected to manage CVD and reduce health system costs. The CVDLINK project aims to address the challenges related to patient health data by developing a pan-European software platform-service for effective data-driven interventions. The platform, built on advanced federated principles, will integrate existing and future sources of medical data, ensuring data security and privacy. It will offer tools for diagnosis and treatment based on artificial intelligence. The project will validate these tools in five countries and promote their use through best practices and awareness campaigns.
The Biomedical Engineering Institute has experience in developing signal processing algorithms, participating in clinical trials, and registering biosignal databases, and will lead three tasks and contribute to 14 tasks. These tasks will include the development of technical requirements and solutions for the security and privacy of the integrated system, the development of a module for medical data annotation using active machine learning algorithms, a clinical study, and a study of the effectiveness of the system using retrospective and prospective data from patients with heart and kidney disease.
The project’s first kickoff meeting in Bucharest, Romania, on 1-2 February, was attended by project leader Vaidotas Marozas, Director of the BMII, and researchers Daivaras Sokas and Ana Rodrigues.
